CVS Shares Rally 16% In A Month: How Does the Competition Measure Up?
Here is how CVS Health (CVS) stacks up against its peers in size, valuation, growth and margin.
- CVS’s operating margin of 2.9% is modest, lower than most peers – trailing AMZN (11.4%).
- CVS’s revenue growth of 5.0% in the last 12 months is low, lagging AMZN, WBA but outpacing WMT, KR, TGT.
- CVS’s stock gained 31.8% over the past year and trades at a PE of 17.2, though peers like AMZN delivered stronger returns.
As a quick background, CVS Health provides health services including pharmacy benefit management, retail prescription drugs, and personal care products through thousands of retail and MinuteClinic locations across the United States.
| CVS | AMZN | WMT | KR | TGT | WBA | |
|---|---|---|---|---|---|---|
| Market Cap ($ Bil) | 91.0 | 2,463.5 | 769.9 | 44.5 | 44.0 | 10.4 |
| Revenue ($ Bil) | 379.0 | 670.0 | 685.1 | 147.0 | 105.9 | 154.6 |
| PE Ratio | 17.2 | 34.9 | 40.9 | 17.2 | 10.5 | -1.6 |
| LTM Revenue Growth | 5.0% | 10.9% | 4.2% | -2.1% | -0.7% | 6.2% |
| LTM Operating Margin | 2.9% | 11.4% | 4.3% | 2.6% | 5.4% | -1.9% |
| LTM FCF Margin | 1.6% | 2.0% | 2.0% | 1.3% | 3.3% | 0.4% |
| 12M Market Return | 31.8% | 35.6% | 27.6% | 29.2% | -35.9% | 31.6% |
Why does this matter? CVS just went up 15.8% in a month – peer comparison puts stock performance, valuation, and financials in context – highlighting whether it is truly outperforming, lagging behind, and above all – can this continue? Read Buy or Sell CVS Stock to see if CVS Health holds up as a quality investment. Furthermore, there is always a risk of fall after a strong rally – see how the stock has dipped and recovered in the past through CVS Dip Buyer Analysis lens.
While peer comparison is critical Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risks while giving upside exposure.
Revenue Growth Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| CVS | 5.0% | – | 4.2% | 10.9% | 10.4% |
| AMZN | 10.9% | – | 11.0% | 11.8% | 9.4% |
| WMT | 4.2% | 5.1% | 6.0% | 6.7% | |
| KR | -2.1% | -1.9% | 1.2% | 7.5% | |
| TGT | -0.7% | -0.8% | -1.6% | 2.9% | |
| WBA | 6.2% | – | 6.2% | 4.8% | 0.1% |
Operating Margin Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| CVS | 2.9% | – | 2.6% | 4.1% | 5.1% |
| AMZN | 11.4% | – | 10.8% | 6.4% | 2.4% |
| WMT | 4.3% | 4.3% | 4.2% | 3.3% | |
| KR | 2.6% | 2.6% | 2.1% | 2.8% | |
| TGT | 5.4% | 5.2% | 5.3% | 3.5% | |
| WBA | -1.9% | – | -1.1% | -5.1% | 0.7% |
PE Ratio Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| CVS | 17.2 | – | 12.2 | 12.2 | 28.4 |
| AMZN | 34.9 | – | 38.8 | 51.5 | -314.4 |
| WMT | 40.9 | 37.4 | 27.4 | 33.1 | |
| KR | 17.2 | 16.4 | 15.2 | 14.3 | |
| TGT | 10.5 | 15.2 | 15.9 | 24.8 | |
| WBA | -1.6 | – | -0.9 | -7.3 | 7.4 |
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.